Iris adds body fluid module to urinalysis analyser:
This article was originally published in Clinica
Executive Summary
Expanding the US market for its iQ200 automated urinalysis analyser, Iris International has gained FDA 510(k) clearance to add to the product a body fluids module for analysing cerebrospinal and serous body fluid. "This is the first in a series of planned extensions of our proprietary urinalysis technology with iQ200 product add-ons targeting the analysis of critical body fluids other than urine," said the Chatsworth, California firm's president and CEO Cesar Garcia. Increasing iQ200's capabilities is expected to enable sales of the analyser platform and related consumables to additional hospitals. It would also allow hospitals with a lower volume of urinalysis tests to justify an iQ200 purchase. Since its launch in August 2003, over 400 iQ200 analysers have been shipped to Iris' customers and distributors worldwide.